Jonathan joined Insight in 2020 as a Vice President and focuses on early-stage investments in biotech and life sciences. He is a Board Member of Gameto and Nanomosaic, and serves as Board Observer for Cirsium Biosciences, Basking Biosciences, and VectorY Therapeutics. Prior to Insight, Jonathan worked at McKinsey & Company in Brussels and New York, serving predominantly life sciences and private equity clients globally. His experience focused on strategic growth, business development, and M&A for large pharma and biotech. In parallel he applied his healthcare expertise to serve Private Equity investors in diligence and operational work for companies supporting the life sciences ecosystem.